grant

A safety, tolerability, pharmacokinetic and efficacy study of azithromycin plus piperaquine as intermittent presumptive treatment in pregnant Papua New Guinean women [ 2012 - 2015 ]

Also known as: Evaluation of azithromycin plus piperaquine as intermittent presumptive treatment in pregnant Papua New Guinean women

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/1036951]

Researchers: Dr Brioni Moore (Principal investigator)

Brief description The purpose of this research is to investigate a new antimalarial combination therapy, azithromycin (AZI) plus piperaquine (PQ), for the prevention of malaria infection in pregnant Papua New Guinean women. It is anticipated that these studies will provide sufficient data to determine if AZI-PQ is a suitable alternative treatment option in PNG, and other countries which have similar malaria epidemiology including the presence of drug resistant parasites.

Funding Amount $AUD 345,684.64

Funding Scheme Early Career Fellowships

Notes CJ Martin Biomedical ECF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]